---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-090748"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-08-17T20:05:47+00:00"
generated_at: "2026-08-17T20:07:44.086854+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma shareholders approve 37.5x increase in authorized shares to 250M

## Summary
- Shareholders approved increase in authorized common stock from 6,666,667 to 250,000,000 shares on Aug 14, 2026.
- Vote: 498,224 for, 190,599 against, 8,485 abstain; no broker non-votes.
- Directors re-elected: Eric Weisblum, Wayne Linsley, Kevin Munoz, Jeff Pavell; each received ~359k for votes.
- Ratified Salberg & Company as independent auditor for FY2026; 690,743 for, 2,571 against.
- Adjournment proposal approved 556,797 for, 131,873 against.

## SEC filing metadata
- accession: 0001213900-26-090748
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-08-17T20:05:47+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026090748/0001213900-26-090748-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026090748/ea0302240-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-090748
- JSON: https://secwatch.observer/filing/0001213900-26-090748.json
- Plain text: https://secwatch.observer/filing/0001213900-26-090748.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.